InfiNovo
Nantong, Jiangsu, China
About InfiNovo
Infinovo was formed in 2016. For the past several years, Infinovo has been focusing on developing an accurate and affordable CGM (Continuous Glucose Monitoring) for patients which will be available for both Type 1 and Type 2 Diabeties. The company has developed a CGM which can compete in the global market for accuracy, durability, and design.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2020)
- Website: infinovo.com
Industries & Categories
B2B, Medical Device, Product Design, Software
Social Profiles
Canonical: https://fsome.com/organization/infinovo-2507548 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.